FIGURE 8.
Gene set enrichment analysis (GSEA) and lower half inhibitory centration (IC50) of chemotherapeutic drugs between the high- and low-risk group based on the pyroptosis-related lncRNA signature in TCGA-HCC. (A) GSEA results suggested that the two risk groups were mainly enriched in the tumor-, immune-, and metabolism-related pathways. (B) A low-risk score was related to an IC50 of chemotherapeutics such as bortezomib, and a high-risk score was related to docetaxel.